The global metastatic cancer treatment market is projected to be worth USD 111.16 Billion by 2027, according to a current analysis by Emergen Research. The metastatic cancer treatment systems market is observing high demand attributed to the increasing incidence of cancer. The disease significantly impacts the societal and economic growth in the US and worldwide and is a major contributor to...